RE­VIEW OF STOCK STRAT­EGY

Flash News Investment - - TECHNICALS -

We had rec­om­mended our read­ers to buy the stock of Aurobindo Pharma Ltd at Rs 789.15 in is­sue no. 3 (dated November 6, 2017). Af­ter our rec­om­men­da­tion, the stock moved higher; how­ever, it failed to sus­tain above Rs 800 mark due to sell­ing pres­sure in the phar­ma­ceu­ti­cals sec­tor. Hence, we ad­vised to exit the stock at Rs 790.55 on November 7, 2017 ahead of the re­sults as his­tory sug­gests that phar­ma­ceu­ti­cal stocks trade with high volatil­ity on the earn­ings day.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.